101 related articles for article (PubMed ID: 19755222)
1. HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicentre experience.
Billinger K; Ostermayer SH; Carminati M; Degiovanni JV; Ewert P; Hess J; Maymone-Martins FA; Qureshi SA; Salmon AP; Schneider M; Wilson N; Sievert H
EuroIntervention; 2006 Feb; 1(4):465-71. PubMed ID: 19755222
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
[TBL] [Abstract][Full Text] [Related]
7. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
8. Patent foramen ovale closure in patients with transient ischemia attack/stroke.
Sievert H; Horvath K; Zadan E; Krumsdorf U; Fach A; Merle H; Scherer D; Schräder R; Spies H; Nowak B; Lissmann-Jensen H
J Interv Cardiol; 2001 Apr; 14(2):261-6. PubMed ID: 12053315
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
[TBL] [Abstract][Full Text] [Related]
10. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
[TBL] [Abstract][Full Text] [Related]
12. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell A; Wilson N; Ormerod O
Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N
Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276
[TBL] [Abstract][Full Text] [Related]
14. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
15. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
Agarwal S; Bajaj NS; Kumbhani DJ; Tuzcu EM; Kapadia SR
JACC Cardiovasc Interv; 2012 Jul; 5(7):777-89. PubMed ID: 22814784
[TBL] [Abstract][Full Text] [Related]
17. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
Spies C; Strasheim R; Timmermanns I; Schraeder R
Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007
[TBL] [Abstract][Full Text] [Related]
18. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
Braun M; Gliech V; Boscheri A; Schoen S; Gahn G; Reichmann H; Haass M; Schraeder R; Strasser RH
Eur Heart J; 2004 Mar; 25(5):424-30. PubMed ID: 15033255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
